Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 17

1.

YAP in Kupffer cells enhances the production of pro-inflammatory cytokines and promotes the development of non-alcoholic steatohepatitis.

Song K, Kwon H, Han C, Chen W, Zhang J, Ma W, Dash S, Gandhi CR, Wu T.

Hepatology. 2019 Oct 14. doi: 10.1002/hep.30990. [Epub ahead of print]

PMID:
31610032
2.

Hepatic Stress Response in HCV Infection Promotes STAT3-Mediated Inhibition of HNF4A-miR-122 Feedback Loop in Liver Fibrosis and Cancer Progression.

Aydin Y, Kurt R, Song K, Lin D, Osman H, Youngquist B, Scott JW, Shores NJ, Thevenot P, Cohen A, Dash S.

Cancers (Basel). 2019 Sep 20;11(10). pii: E1407. doi: 10.3390/cancers11101407.

3.
4.

A Transforming Growth Factor-β and H19 Signaling Axis in Tumor-Initiating Hepatocytes That Regulates Hepatic Carcinogenesis.

Zhang J, Han C, Ungerleider N, Chen W, Song K, Wang Y, Kwon H, Ma W, Wu T.

Hepatology. 2019 Apr;69(4):1549-1563. doi: 10.1002/hep.30153. Epub 2018 Dec 31.

PMID:
30014520
5.

Epigenetic Silencing of miRNA-34a in Human Cholangiocarcinoma via EZH2 and DNA Methylation: Impact on Regulation of Notch Pathway.

Kwon H, Song K, Han C, Zhang J, Lu L, Chen W, Wu T.

Am J Pathol. 2017 Oct;187(10):2288-2299. doi: 10.1016/j.ajpath.2017.06.014.

6.

15-hydroxyprostaglandin dehydrogenase (15-PGDH) prevents lipopolysaccharide (LPS)-induced acute liver injury.

Yao L, Chen W, Song K, Han C, Gandhi CR, Lim K, Wu T.

PLoS One. 2017 Apr 19;12(4):e0176106. doi: 10.1371/journal.pone.0176106. eCollection 2017.

7.

miR-223 Deficiency Protects against Fas-Induced Hepatocyte Apoptosis and Liver Injury through Targeting Insulin-Like Growth Factor 1 Receptor.

Qadir XV, Chen W, Han C, Song K, Zhang J, Wu T.

Am J Pathol. 2015 Dec;185(12):3141-51. doi: 10.1016/j.ajpath.2015.08.020.

8.

Active glycolytic metabolism in CD133(+) hepatocellular cancer stem cells: regulation by MIR-122.

Song K, Kwon H, Han C, Zhang J, Dash S, Lim K, Wu T.

Oncotarget. 2015 Dec 1;6(38):40822-35. doi: 10.18632/oncotarget.5812.

9.

Inhibition of hedgehog signaling ameliorates hepatic inflammation in mice with nonalcoholic fatty liver disease.

Kwon H, Song K, Han C, Chen W, Wang Y, Dash S, Lim K, Wu T.

Hepatology. 2016 Apr;63(4):1155-69. doi: 10.1002/hep.28289. Epub 2015 Dec 18.

10.

miR-150 Deficiency Protects against FAS-Induced Acute Liver Injury in Mice through Regulation of AKT.

Chen W, Han C, Zhang J, Song K, Wang Y, Wu T.

PLoS One. 2015 Jul 21;10(7):e0132734. doi: 10.1371/journal.pone.0132734. eCollection 2015.

11.

MiR-122 in hepatitis B virus and hepatitis C virus dual infection.

Song K, Han C, Dash S, Balart LA, Wu T.

World J Hepatol. 2015 Mar 27;7(3):498-506. doi: 10.4254/wjh.v7.i3.498. Review.

12.

Deletion of Mir155 prevents Fas-induced liver injury through up-regulation of Mcl-1.

Chen W, Han C, Zhang J, Song K, Wang Y, Wu T.

Am J Pathol. 2015 Apr;185(4):1033-44. doi: 10.1016/j.ajpath.2014.12.020.

13.

Omega-3 Polyunsaturated Fatty Acids Upregulate 15-PGDH Expression in Cholangiocarcinoma Cells by Inhibiting miR-26a/b Expression.

Yao L, Han C, Song K, Zhang J, Lim K, Wu T.

Cancer Res. 2015 Apr 1;75(7):1388-98. doi: 10.1158/0008-5472.CAN-14-2561. Epub 2015 Feb 17.

14.

Persistent hepatitis C virus infection impairs ribavirin antiviral activity through clathrin-mediated trafficking of equilibrative nucleoside transporter 1.

Panigrahi R, Chandra PK, Ferraris P, Kurt R, Song K, Garry RF, Reiss K, Coe IR, Furihata T, Balart LA, Wu T, Dash S.

J Virol. 2015 Jan;89(1):626-42. doi: 10.1128/JVI.02492-14. Epub 2014 Oct 22.

15.

HCV infection selectively impairs type I but not type III IFN signaling.

Chandra PK, Bao L, Song K, Aboulnasr FM, Baker DP, Shores N, Wimley WC, Liu S, Hagedorn CH, Fuchs SY, Wu T, Balart LA, Dash S.

Am J Pathol. 2014 Jan;184(1):214-29. doi: 10.1016/j.ajpath.2013.10.005. Epub 2013 Nov 9.

16.

Epigenetic regulation of MicroRNA-122 by peroxisome proliferator activated receptor-gamma and hepatitis b virus X protein in hepatocellular carcinoma cells.

Song K, Han C, Zhang J, Lu D, Dash S, Feitelson M, Lim K, Wu T.

Hepatology. 2013 Nov;58(5):1681-92. doi: 10.1002/hep.26514. Epub 2013 Sep 17.

17.

miR-101 inhibits cholangiocarcinoma angiogenesis through targeting vascular endothelial growth factor (VEGF).

Zhang J, Han C, Zhu H, Song K, Wu T.

Am J Pathol. 2013 May;182(5):1629-39. doi: 10.1016/j.ajpath.2013.01.045.

Supplemental Content

Loading ...
Support Center